Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions

Journal of Virology

Volumn 86, Issue 11, 2012, Pages 5974-5991

  Paudel, Nitika ^a   Sadagopan, Sathish ^a   Chakraborty, Sayan ^a   Sarek, Grzegorz ^b   Ojala, Päivi M ^b   Chandran, Bala ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIN; CASPASE 3; LATENCY ASSOCIATED NUCLEAR ANTIGEN; LATENCY ASSOCIATED NUCLEAR ANTIGEN 1; PROTEIN BAX; PROTEIN BCL 2; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; SERINE; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; LATENCY-ASSOCIATED NUCLEAR ANTIGEN; NUCLEAR PROTEIN; PANCREATIC RIBONUCLEASE; VIRUS ANTIGEN;

APOPTOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL CYCLE REGULATION; CELL LYSATE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; ENZYME MODIFICATION; GEL FILTRATION CHROMATOGRAPHY; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOPRECIPITATION; LATENT VIRUS INFECTION; MOLECULAR WEIGHT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; PROTEIN TRANSPORT; UPREGULATION; VIRUS GENOME; VIRUS LATENCY; CELL LINE; ENDOTHELIUM CELL; GEL CHROMATOGRAPHY; GENE DELETION; HOST PATHOGEN INTERACTION; METABOLISM; PATHOGENICITY; PROTEIN ANALYSIS; VIROLOGY;

HUMAN HERPESVIRUS 8; LANA;

ANTIGENS, VIRAL; APOPTOSIS; CELL LINE; CHROMATOGRAPHY, GEL; ENDOTHELIAL CELLS; HERPESVIRUS 8, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOPRECIPITATION; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPPING; RIBONUCLEASE, PANCREATIC; SEQUENCE DELETION;

EID: 84863577285     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00070-12     Document Type: Article

References (49)

1. Akula SM, Pramod NP, Wang FZ, Chandran B. 2002. Integrin alpha3beta1 (CD 49c/29) is a cellular receptor for Kaposi's sarcomaassociated herpesvirus (KSHV/HHV-8) entry into the target cells. Cell 108:407-419.
2. Ballestas ME, Chatis PA, Kaye KM. 1999. Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641-644.
3. Cai X, et al. 2005. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc. Natl. Acad. Sci. U. S. A. 102:5570-5575.
4. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N. Engl. J. Med. 332:1186-1191.
5. Chang Y, et al. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
6. Chen W, Dittmer DP. 2011. Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 85:9495-9505.
7. Cotter MA, II, Robertson ES. 1999. The latency-associated nuclear antigen tethers the Kaposi's sarcoma-associated herpesvirus genome to host chromosomes in body cavity-based lymphoma cells. Virology 264:254-264.
8. Dull T, et al. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471.
9. Eppenberger U, et al. 1998. Markers of tumor angiogenesis and proteolysis independently define high- and low-risk subsets of node-negative breast cancer patients. J. Clin. Oncol. 16:3129-3136.
10. Fakhari FD, Dittmer DP. 2002. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J. Virol. 76:6213-6223.
11. Farrell PJ, Allan GJ, Shanahan F, Vousden KH, Crook T. 1991. p53 is frequently mutated in Burkitt's lymphoma cell lines.EMBOJ. 10:2879-2887.
12. Friborg J, Jr, Kong W, Hottiger MO, Nabel GJ. 1999. p53 inhibition by the LANA protein of KSHV protects against cell death. Nature 402:889-894.
13. Fujimuro M, et al. 2003. A novel viral mechanism for dysregulation of beta-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat. Med. 9:300-306.
14. Ganem D. 2007. Kaposi's sarcoma-associated herpesvirus, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
15. Gao X, Xu Z. 2008. Mechanisms of action of angiogenin. Acta Biochim. Biophys. Sin. 40:619-624.
16. Green DR, Kroemer G. 2009. Cytoplasmic functions of the tumour suppressor p53. Nature 458:1127-1130.
17. Guasparri I, Keller SA, Cesarman E. 2004. KSHV vFLIP is essential for the survival of infected lymphoma cells. J. Exp. Med. 199:993-1003.
18. Hirukawa S, Olson KA, Tsuji T, Hu GF. 2005. Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice. Clin. Cancer Res. 11:8745-8752.
19. Hu GF. 1998. Neomycin inhibits angiogenin-induced angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 95:9791-9795.
20. Kaul R, Verma SC, Robertson ES. 2007. Protein complexes associated with the Kaposi's sarcoma-associated herpesvirus-encoded LANA. Virology 364:317-329.
21. Kishimoto K, Liu S, Tsuji T, Olson KA, Hu GF. 2005. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 24:445-456.
22. Krishnan HH, et al. 2004. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78:3601-3620.
23. Kwun HJ, et al. 2007. Kaposi's sarcoma-associated herpesvirus latencyassociated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J. Virol. 81:8225-8235.
24. Lan K, Kuppers DA, Verma SC, Robertson ES. 2004. Kaposi's sarcomaassociated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virusmediated control of latency. J. Virol. 78:6585-6594.
25. Li S, Yu W, Hu GF. 2011. Angiogenin inhibits nuclear translocation of apoptosis inducing factor in a Bcl-2-dependent manner. J. Cell. Physiol. 227:1639-1644.
26. Li S, Yu W, Kishikawa H, Hu GF. 2010. Angiogenin prevents serum withdrawal-induced apoptosis of P19 embryonal carcinoma cells. FEBS J. 277:3575-3587.
27. Miyoshi H, Blomer U, Takahashi M, Gage FH, Verma IM. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
28. Moroianu J, Riordan JF. 1994. Nuclear translocation of angiogenic proteins in endothelial cells: an essential step in angiogenesis. Biochemistry 33:12535-12539.
29. Naranatt PP, Akula SM, Zien CA, Krishnan HH, Chandran B. 2003. Kaposi's sarcoma-associated herpesvirus induces the phosphatidylinositol 3-kinase-PKC-zeta-MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J. Virol. 77:1524-1539.
30. Naranatt PP, et al. 2004. Host gene induction and transcriptional reprogramming in Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8)-infected endothelial, fibroblast, and B cells: insights into modulation events early during infection. Cancer Res. 64:72-84.
31. Paudel N, Sadagopan S, Balasubramanian S, Chandran B. 2011. Kaposi's sarcoma associated herpesvirus latency associated nuclear antigen and angiogenin interact with common host proteins including annexin A2, which is essential for survival of latently infected cells. J. Virol. 86:1589-1607.
32. Petre CE, Sin SH, Dittmer DP. 2007. Functional p53 signaling in Kaposi's sarcoma-associated herpesvirus lymphomas: implications for therapy. J. Virol. 81:1912-1922.
33. Radkov SA, Kellam P, Boshoff C. 2000. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat. Med. 6:1121-1127.
34. Renne R, et al. 2001. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J. Virol. 75:458-468.
35. Sadagopan S, et al. 2009. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J. Virol. 83:3342-3364.
36. Sadagopan S, Valiya Veettil M, Paudel N, Bottero V, Chandran B. 2011. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle. J. Virol. 85: 2666-2685.
37. Sadagopan S, et al. 23 January 2012. Angiogenin functionally interacts with p53 and regulates p53-mediated apoptosis and cell survival. Oncogene [Epub ahead of print.] doi:10.1038/onc.2011.648.
38. Sarek G, Jarviluoma A, Ojala PM. 2006. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 107:725-732.
39. Sarek G, et al. 2007. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas. J. Clin. Investig. 117:1019-1028.
40. Sharma-Walia N, et al. 2010. Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion. PLoS Pathog. 6:e1000777.
41. Shieh SY, Ikeda M, Taya Y, Prives C. 1997. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91:325-334.
42. Sivakumar R, et al. 2008. Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J. Virol. 82:1759-1776.
43. St. Clair DK, Rybak SM, Riordan JF, Vallee BL. 1988. Angiogenin abolishes cell-free protein synthesis by specific ribonucleolytic inactivation of 40S ribosomes. Biochemistry 27:7263-7268.
44. Szekely L, et al. 1999. Human herpesvirus-8-encoded LNA-1 accumulates in heterochromatin-associated nuclear bodies. J. Gen. Virol. 80:2889-2900.
45. Vart RJ, et al. 2007. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6 and G-protein-coupled receptor regulate angiopoietin-2 expression in lymphatic endothelial cells. Cancer Res. 67:4042-4051.
46. Vrancken K, Vervaeke P, Balzarini J, Liekens S. 2011. Viruses as key regulators of angiogenesis. Rev. Med. Virol. 21:181-200.
47. Xu ZP, Tsuji T, Riordan JF, Hu GF. 2003. Identification and characterization of an angiogenin-bindingDNAsequence that stimulates luciferase reporter gene expression. Biochemistry 42:121-128.
48. Ye FC, et al. 2008. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency. J. Virol. 82:4235-4249.
49. Yoshioka N, Wang L, Kishimoto K, Tsuji T, Hu GF. 2006. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc. Natl. Acad. Sci. U. S. A. 103:14519-14524.